Related Experiment Video
Updated: Mar 25, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Contemporary mechanical circulatory support therapy for postcardiotomy shock
Shinichi Fukuhara1, Koji Takeda2, Arthur Reshad Garan3
1Division of Cardiac, Thoracic and Vascular Surgery, Columbia University Medical Center, 177 Fort Washington Ave, New York, NY, 10032, USA. shin922@gmail.com.
Mechanical circulatory support (MCS) has advanced, but postcardiotomy shock (PCS) remains a critical condition with over 50% mortality. Improving patient selection and timely MCS intervention are key to reducing PCS deaths.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
- Critical Care
Background:
- Mechanical circulatory support (MCS) has seen significant clinical advancements, particularly durable left ventricular assist devices.
- Short-term MCS options include venoarterial extracorporeal membrane oxygenation and various ventricular assist devices (VADs).
- Postcardiotomy shock (PCS) is a rare but severe complication following cardiac surgery, characterized by heart failure and high mortality.
Purpose of the Study:
- To highlight the persistent high mortality associated with postcardiotomy shock (PCS).
- To emphasize the critical role of mechanical circulatory support (MCS) in managing PCS.
- To underscore the need for a clear definition and improved strategies for PCS management.
Main Methods:
- Review of current mechanical circulatory support (MCS) technologies.
- Analysis of clinical outcomes and mortality rates in postcardiotomy shock (PCS) patients.
- Discussion of the challenges in defining and managing PCS.
Main Results:
- In-hospital mortality for PCS patients remains high, exceeding 50% despite technological improvements in MCS.
- The most common indication for MCS is postcardiotomy shock (PCS).
- A lack of a clear, standardized definition for PCS hinders scientific analysis and evidence comparison.
Conclusions:
- Optimizing patient selection criteria and prompt initiation of MCS are crucial for improving outcomes in PCS.
- A unified definition and concerted effort from the cardiovascular society are imperative for effective PCS treatment strategies.
- Further research and standardized approaches are needed to reduce the substantial morbidity and mortality associated with PCS.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies

